$OBIO News

Orchestra BioMed to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

Orchestra BioMed to Participate in the Wells Fargo 21st Annual Healthcare Conference

Piper Sandler Reiterates Overweight on Orchestra BioMed Hldgs, Raises Price Target to $10

Orchestra BioMed Holdings, Inc. (OBIO) Reports Q2 Loss, Misses Revenue Estimates

Orchestra BioMed Hldgs Q2 EPS $(0.38) Misses $(0.37) Estimate, Sales $88.000K Miss $121.400K Estimate

Orchestra BioMed Joins Russell 3000® and Russell 2000® Indexes

Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Favourable Signals For Orchestra BioMed Holdings: Numerous Insiders Acquired Stock

B. Riley Securities Maintains Buy on Orchestra BioMed Hldgs, Lowers Price Target to $10

Orchestra BioMed to Participate in the Jefferies Global Healthcare Conference

HC Wainwright & Co. Reiterates Buy on Orchestra BioMed Hldgs, Maintains $10 Price Target

Barclays Maintains Overweight on Orchestra BioMed Hldgs, Raises Price Target to $13

Orchestra BioMed Holdings, Inc. (OBIO) Reports Q1 Loss, Lags Revenue Estimates

Orchestra BioMed Hldgs Q1 EPS $(0.33) Beats $(0.41) Estimate, Sales $110.000K Miss $190.750K Estimate

TScan Therapeutics, Inc. (TCRX) Reports Q1 Loss, Lags Revenue Estimates

NovoCure (NVCR) Reports Q1 Loss, Beats Revenue Estimates

Orchestra Biomed Holdings Inc (NASDAQ:OBIO) Fits the Minervini High-Growth Momentum Template

Orchestra BioMed Hldgs Q4 EPS $0.26 Beats $(0.39) Estimate, Sales $30.917M Beat $878.600K Estimate

Orchestra BioMed Announces Presentations Highlighting AVIM Therapy Potential Impact on Hypertensive Heart Disease and Heart Failure at THT and CRT

Orchestra BioMed Announces Presentations Highlighting Atrioventricular Interval Modulation Therapy For Heart Disease Patients